Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cells

Journal of Investigative Dermatology

Volumn 132, Issue 7, 2012, Pages 1877-1885

  Sakaguchi, Masanobu ^a   Oka, Masahiro ^a   Iwasaki, Tetsushi ^b   Fukami, Yasuo ^b   Nishigori, Chikako ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

EID: 84862332432     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.45     Document Type: Article

References (34)

1. Aggarwal BB, Kunnumakkara AB, Harikumar KB et al. (2009) Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann NY Acad Sci 1171:59-76
2. Aziz MH, Hafeez BB, Sand JM et al. (2010) Protein kinase Ce mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene 29:3100-9
3. Aziz MH, Manoharan HT, Church DR et al. (2007) Protein kinase Ce interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res 67:8828-38 (Pubitemid 47437459)
4. Bowman T, Garcia R, Turkson J et al. (2000) STATs in oncogenessis. Oncogene 19:2474-88
5. Bromberg J, Chen X (2001) STAT proteins: signal transducers and activators of transcription. Methods Enzymol 333:138-51 (Pubitemid 32507305)
6. Chung J, Uchida E, Grammer TC et al. (1997) STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17:6508-16 (Pubitemid 27451197)
7. Darnell JE Jr (1997) STATs and gene regulation. Science 277:1630-5
8. Davies H, Bignell GR, Cox C et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-54 (Pubitemid 34716871)
9. Decker T, Kovarik P (2000) Serine phosphorylation of STATs. Oncogene 19:2628-37 (Pubitemid 30339219)
10. Fu AK, Fu WY, Ng AK et al. (2004) Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proc Natl Acad Sci USA 101:6728-33 (Pubitemid 38586042)
11. Gollob JA, Schnipper CP, Murphy EA et al. (1999) The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation. J Immunol 162:4472-81 (Pubitemid 29314844)
12. Gonzalez FA, Raden DL, Davis RJ (1991) Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem 266:22159-63 (Pubitemid 21908629)
13. Heath EM, Kaufman KL, Christopherson RI (2011) B-RAF: a contributor to the melanoma phenotype. Int J Biochem Cell Biol 43:29-32
14. Hocker TL, Singh MK, Tsao H (2008) Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside. J Invest Dermatol 128:2575-95
15. Jain N, Zhang T, Kee WH et al. (1999) Protein kinase C d associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J Biol Chem 274:24392-400
16. Kreis S, Munz GA, Haan S et al. (2007) Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases. Mol Cancer Res 5:1331-41
17. Levy DE, Lee CK (2000) What does Stat3 do? J Clin Invest 109:1143-8 (Pubitemid 34496591)
18. Lim CP, Cao X (1999) Serine phosphorylation and negative regulation of Stat3 by JNK. J Biol Chem 274:31055-61
19. Lopez-Bergami P, Fitchman B, Ronai Z (2008) Understanding signaling cascades in melanoma. Photochem Photobiol 84:289-306 (Pubitemid 351424029)
20. Messina JL, Yu H, Riker AI et al. (2008) Activated stat-3 in melanoma. Cancer Control 15:196-201
21. Niu G, Bowman T, Huang M et al. (2002) Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene 21:7001-10 (Pubitemid 35252974)
22. Oka M, Kageyama A, Fukunaga M et al. (2004) Phosphatidylinositol 3-kinase/Akt-dependent and -independent protection against apoptosis in normal human melanocytes. J Invest Dermatol 123:930-6 (Pubitemid 39391940)
23. Oka M, Kikkawa U, Nishigori C (2007) Protein kinase C-bII represses hepatocyte growth factor-induced invasion by preventing the association of adapter protein Gab1 and phosphatidylinositol 3-kinase in melanoma cells. J Invest Dermatol 128:188-95 (Pubitemid 350249378)
24. Oka M, Sumita N, Sakaguchi M et al. (2009) 12-O-tetradecanoylphorbol-13- acetate inhibits melanoma growth by inactivation of STAT3 through protein kinase C-activated tyrosine phosphatase(s). J Biol Chem 284:30416-23
25. O'Rourke L, Shepherd PR (2002) Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: role in regulating STAT3 Ser727 phosphorylation and DNA binding. Biochem J 364:875-879 (Pubitemid 34680866)
26. Russo AE, Torrisi E, Bevelacqua Y et al. (2009) Melanoma: molecular pathogenesis and emerging therapies (review). Int J Oncol 34:1481-9
27. Schuringa JJ, Schepers H, Vellenga E et al. (2001) Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett 495:71-6 (Pubitemid 32367976)
28. Seiji M, Takematsu H, Hosokawa M et al. (1983) Acral melanoma in Japan. J Invest Dermatol 80(Suppl):S56-60
29. Smalley KS, Herlyn M (2005) Targeting intracellular signaling pathways as a novel strategy in melanoma therapeutics. Ann NY Acad Sci 1059:16-25 (Pubitemid 43211606)
30. Smalley KS, Lioni M, Dalla Palma M et al. (2008) Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas. Mol Cancer Ther 7:2876-83
31. Tsai J, Lee JT, Wang W et al. (2008) Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci USA 105:3041-6 (Pubitemid 351723664)
32. Wen Z, Zhong Z, Darnell JE Jr (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-50
33. Yokogami K, Wakisaka S, Avruch J et al. (2000) Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol 10:47-50 (Pubitemid 30057415)
34. Zhong Z, Wen Z, Darnell JE Jr (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-8 (Pubitemid 24144493)